<DOC>
	<DOC>NCT00846391</DOC>
	<brief_summary>A study to assess the safety and efficacy of MK8245 as monotherapy compared to placebo.</brief_summary>
	<brief_title>A Study to Assess the Safety and Efficacy of MK8245 in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control (MK8245-005 AM2)</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<criteria>Have Type 2 Diabetes Mellitus 18 to 65 years of age History of Type 1 Diabetes or ketoacidosis Have been treated with lipid lowering medications 4 weeks before starting the study Have started on a weight loss program and not in the maintenance phase or have started weight loss medication within the last 12 weeks Have had surgery in the last 30 days History of active liver disease History of coronary heart disease or congestive heart failure Have had a stroke or transient ischemic neurological disorder in the past 6 months Are Human Immunodeficiency Virus (HIV) Positive</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>